Transethosomes: A Promising Challenge for Topical Delivery Short Title: Transethosomes for Topical Delivery

Abstract

Skin provides an excellent barrier to molecular transport, as the stratum corneum is the most formidable barrier to the passage of most pharmaceuticals. Various attempts have been made to improve drug administration into the body through intact skin. Though very few routes are as attractive as the topical route, drug transport through the skin is challenging. To overcome the challenges, researchers have found a system in which the drug is encapsulated into the vesicle, penetrating deeper into the skin to hit the target site. Vesicular systems like transethosome, an ultra- deformable vesicle (UDV), tend to accumulate in the skin layers. Since transethosomes have small particle size and can easily alter the shape of vesicles compared to other vesicular systems, they can penetrate through the layers of skin. Hence, the drug encapsulated into transethosomes can easily reach the target site. Transethosomes consist of ethanol and phospholipids along with an edge activator. Ethanol and edge activator help to enhance the skin permeation of transethosomes. Various methods of preparation of transethosomes, comparison of transethosomes with other lipid vesicles, characterization of transethosomes, and application of transethosomes have been covered in this review. Transethosomes can deliver a different variety of drugs, such as anticancer, corticosteroids, proteins and peptides, analgesics

Key words

Topical delivery - vesicles - phospholipid - edge activator - transethosomes

Publication History

Received: 16 August 2022

Accepted: 28 October 2022

Article published online:
03 February 2023

• References

• 1 Dubey V. et al. Vesicles as tools for the modulation of skin permeability. Exp opinion on dr del 2007; 4: 579-593
• 2 Yu YQ. et al. Enhancing permeation of drug molecules across the skin via delivery in nanocarriers: Novel strategies for effective transdermal applications. Frontiers in bioe and biotech 2021; 9: 200
• 3 Domínguez-Delgado CL, Rodríguez-Cruz IM, López-Cervantes M. et al. The Skin a Valuable Route forAdministration of Drugs. Current Technologies to Increase the Transdermal Delivery of Drugs. (The Netherlands: Bentham Science Publishers Ltd); 2010
• 4 Carlsson J. Skin Models for Screening of Topical Delivery. Experimentaldermatology 2020; 17: 1063-1072
• 5 Sala M, Diab R, Elaissari A. et al. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications. International J of pharm 2018; 535: 1-17
• 6 Benson HA, Watkinson AC. eds. Topical and transdermal drug delivery:principles and practice. John Wiley & Sons; 2012
• 7 Suh H, Shin J, Kim YC. Microneedle patches for vaccine delivery. Clinical and exp vaccine research 2014; 3: 42-49
• 8 Stevens NE, Cowin AJ. Overcoming the challenges of topical antibody administration for improving healing outcomes: a review of recent laboratory and clinical approaches. Wound Practice & Research. J of the Australian Wound Mana Ass 2017; 25: 188-194
• 9 Alkilani AZ, McCrudden MT, Donnelly RF. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of thestratum corneum. J of Pharmaceutics 2015; 7: 438-470
• 10 Riviere JE, Monteiro-Riviere NA. Dermal absorption models in toxicologyand pharmacology (CRC Press). 2005
• 11 Hachem JP, Man MQ, Crumrine D. et al. Sustained serine proteases activity by prolonged increasein pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J of investigative dermatology 2005; 125: 510-520
• 12 Nagula RL, Wairkar S. Recent advances in topical delivery of flavonoids: A review. J of cont release 2019; 296: 190-201
• 13 Ishida Yamamoto A, Igawa S, Kishibe M. et al. Clinical and molecular implications of structural changes to desmosomes and corneodesmosomes. The J of Derma 2018; 45: 385-389
• 14 Lee AY. Molecular mechanism of epidermal barrier dysfunction as primary abnormalities. I J of molecular sciences 2020; 21: 1194
• 15 Matsui T, Amagai M. Dissecting the formation, structure and barrier functionof the stratum corneum. I immunology 2015; 27: 269-280
• 16 Jonca N, Leclerc EA, Caubet C. et al. Corneodesmosomes and corneodesmosin: from the s tratum corneum cohesion to thepathophysiology of genodermatoses. Eur J of Dermatology 2011; 21: 35-42
• 17 Kezic S, Jakasa I. Filaggrin and skin barrier function. Skin Barrier Function 2016; 491-497
• 18 Kirschner N, Rosenthal R, Furuse M. et al. Contribution of tight junction proteins to ion, macromolecule, and water barrier in keratinocytes. J of Invest Dermatology 2013; 133: 1161-1169
• 19 Adams MP, Mallet DG, Pettet GJ. Towards a quantitative theory of epidermal calcium profile formation in unwounded skin. (PLoS One). 2015
• 20 Lai-Cheong JE, McGrath JA. Structure and function of skin, hair and nails. (Medicine). 2013
• 21 Walters KA. ed., 2002. Dermatological and transdermal formulations. CRC Press;
• 22 Trommer H, Neubert RHH. Overcoming the stratum corneum: the modulation of skin penetration. Skin pharmacology and physiology 2006; 19: 106-121
• 23 Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J of pharmaceutical Sci 2001; 14: 101-114
• 24 Bolzinger MA, Briançon S, Pelletier J. et al. Penetration of drugs through skin, a complex rate-controlling membrane. Current opinion in colloid & interface science 2012; 17: 156-165
• 25 Erdogan S. Liposomal nanocarriers for tumor imaging. J l of Biomedical Nanotechnology 2009; 5: 141-150
• 26 Sinico C, Fadda AM. Vesicular carriers for dermal drug delivery. Expert opinion on drug delivery 2009; 6: 813-825
• 27 Ahad A, Raish M, Al-Jenoobi FI. et al. Sorbitane monostearate and cholesterol based niosomes for oral delivery of telmisartan. Current drug delivery 2018; 15: 260-266
• 28 Dua JS, Rana AC, Bhandari AK. Liposome: methods of preparation and applications. Int J Pharm Stud Res 2012; 3: 14-20
• 29 Egbaria K, Weiner N. Liposomes as a topical drug delivery system. Advanced drug delivery reviews 1990; 5: 287-300
• 30 Sharma A, Sharma US. Liposomes in drug delivery: progress and limitations. Int J of pharmaceutics 1997; 154: 123-140
• 31 Alavi M, Karimi N, Safaei M. Application of various types of liposomes in drug delivery systems. Ad Phar bulletin 2017; 7(1): 3-9
• 32 Barenholz Y. Liposome application: problems and prospects. Current opinion in colloid & interface science 2001; 6: 66-77
• 33 Sharma AK. Scientometric analysis of global publication output in liposome research. (Library Philosophy and Practice). 2021
• 34 Park JW. Liposome-based drug delivery in breast cancer treatment. Breast Cancer Research 2002; 4: 1-5
• 35 Egbaria K, Weiner N. Liposomes as a topical drug delivery system. Advanced drug delivery reviews 1990; 5: 287-300
• 36 Weiner N, Lieb L, Niemiec S. et al. Liposomes: a novel topical delivery system for pharmaceutical and cosmetic applications. J of Drug Targeting 1994; 2: 405-410
• 37 Kaur D, Kumar S. Niosomes: present scenario and future aspects. J of drug delivery and therapeutics 2018; 8: 35-43
• 38 Lohumi A. A novel drug delivery system: niosomes review. J of drug delivery and therapeutics 2012; 2
• 39 Haider MD, Kanoujia J, Tripathi CB. et al. Pioglitazone loaded vesicular carriers for anti-diabetic activity: development and optimization as per central composite design. J of Pharmaceutical Scie and Pharmacology 2015; 2: 11-20
• 40 Gala U, Chauhan H. Taste masking techniques in the pharmaceutical industry. American Pharmaceutical Rev 2014; 17: 492-498
• 41 Sarker A, Shimu IJ, Alam SAA. Niosome: as dermal drug delivery tool. IOSR J of Pharmacy and Biological Sci 2015; 10: 73-79
• 42 Balakrishnan P, Shanmugam S, Lee WS. et al. Formulation and in vitro assessment of minoxidilniosomes for enhanced skin delivery. Intl J of pharmaceutics 2009; 377: 1-8
• 43 Abdelbary AA, AbouGhaly MH. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box–Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J of pharmaceutics 2015; 485: 235-243
• 44 Pando D, Matos M, Gutiérrez G. et al. Formulation of resveratrol entrapped niosomes for topical use. Colloids and surfaces B: Biointerfaces 2015; 128398-128404
• 45 Malay KD, Narahari NP. Sorbitan ester niosomes for topical delivery of rofecoxib. Indian J of exp Biology 2011; 49438-49445
• 46 Tavano L, Alfano P, Muzzalupo R. et al. Niosomes vs microemulsions: new carriers for topical delivery of capsaicin. Colloids and surfaces B: Biointerfaces 2011; 87: 333-339
• 47 Chauhan N, Kumar K, Pant NC. An updated review on transfersomes: a novel vesicular system for transdermal drug delivery. Uni J of Pharm Research 2017; 2: 42-45
• 48 Chen J, Lu WL, Gu W. et al. Skin permeation behavior of elastic liposomes: role of formulation ingredients. Expert opinion on drug delivery 2013; 10: 845-856
• 49 Elsayed MM, Cevc G. The vesicle-to-micelle transformation of phospholipid– cholate mixed aggregates: a state-of-the-art analysis including membrane curvature effects. Biochimica et Biophysica Acta (BBA)-Biomembranes 2011; 1808: 140-153
• 50 Opatha SAT, Titapiwatanakun V, Chutoprapat R. Transfersomes: A promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics 2020; 12: 855
• 51 Chauhan P, Tyagi BK. Herbal novel drug delivery systems and transfersomes. J of Drug Deli and Therapeutics 2018; 8: 162-168
• 52 Benson HA. Transfersomes for transdermal drug delivery. Expert opinion on drug delivery 2006; 3: 727-737
• 53 Modi CD, Bharadia PD. Transfersomes: new dominants for transdermal drug delivery. Am J Pharm Tech Res 2012; 2: 71-91
• 54 Vinod KR, Kumar MS, Anbazhagan S. et al. Critical issues related to transfersomes-novel vesicular system. ACTA Scientiarum Polonorum Technologia Alimentaria 2012; 11: 67-82
• 55 Walve JR, Bakliwal SR, Rane BR. et al. Transfersomes: a surrogated carrier for transdermal drug delivery system. Portal Regional da BVS 2011; 1: 2-3
• 56 Sudhakar CK, Jain S, Charyulu RN. A comparison study of liposomes, transfersomes and ethosomes bearing lamivudine. Int J of Pharm Scie and Research 2016; 7: 4214
• 57 Manosroi A, Jantrawut P, Khositsuntiwong N. et al. Novel elastic nanovesicles for cosmeceutical and pharmaceutical applications. Chiang Mai J Sci 2009; 36: 168-178
• 58 Wakade VS, Shende P. Strategic advancements and multimodal applications of biofilm therapy. Expert Opinion on Biological Therapy 2021; 21: 395-412
• 59 Aute PP, Kamble MS, Chaudhari PD. et al. A comprehensive review on ethosomes. Int Jof Research and Development in Pharmacy and Life Sci 2012; 2: 218-224
• 60 Almukhtar RM, Fabi SG. Cosmeceuticals and Delivery Mechanisms: Skin Function and Skin Barrier. In Cosmeceuticals: Karger Publishers; 2021
• 61 Parashar T, Sachan R, Singh V. et al. Ethosomes: a recent vesicle of transdermal drug delivery system. Int J of research and development in pharmacy and life Sci 2013; 2: 285-292
• 62 Satyam G, Shivani S, Garima G. Ethosomes: A novel tool for drug delivery through the skin. J Pharm Res 2010; 3: 688-691
• 63 Ramakrishna GA, Manobar SD, Bhanudas SR. Ethosomes: carrier for enhanced transdermal drug delivery system. Circulation 2014; 12: 380-387
• 64 Nandure HP, Puranik P, Giram P. et al. Ethosome: A Novel Drug Carrier. Int J of Pharmaceutical Research & Allied Sciences 2013; 2: 18-30
• 65 Laib S, Routh AF. Fabrication of colloidosomes at low temperature for the encapsulation of thermally sensitive compounds. J of colloid and interface Sci 2008; 317: 121-129
• 66 Wahid AA, Ravouru N, Lakshman SR. Ethosomes: A tool for transdermal drug delivery. Current Trends in Biotech and Pharmacy 2011; 5: 972-981
• 67 Deepika P, Rathore KS. Noveland most prominent career system transethosome for topical delivery. Pharmceutical resonance 2021; 3
• 68 Nainwal N, Jawla S, Singh R. et al. Transdermal applications of ethosomes – a detailed review. Journal of liposome research 2019; 29: 103-113
• 69 Kumar KP, Radhika PR, Sivakumar T. Ethosomes – a priority in transdermal drug delivery. Int J of Advances in Pharmaceutical Sci 2010; 1: 285-292
• 70 Ascenso A, Raposo S, Batista C. et al. Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes. Int J of nanomedicine 2015; 105837
• 71 Garg V, Singh H, Bhatia A. et al. Systematic development of transethosomal gel system of piroxicam: formulation optimization, in vitroevaluation, and ex vivo assessment. AAPS pharmscitech 2017; 18: 58-71
• 72 Mahrab Robert M, Kalia YN. New developments in topical antifungal therapy. American J of Drug Delivery 2006; 4: 231-247
• 73 Vinod KR, Kumar MS, Anbazhagan S. et al. Critical issues related to transfersomes-novel vesicular system. ACTA Scientiarum Polonorum Technologia Alimentaria 2012; 11: 67-82
• 74 Kesharwani R, Patel DK, Sachan A. et al. Ethosomes: A novel approach for transdermal and topical drug delivery. Research J of Topical and CosmeticSci 2015; 6: 15-20
• 75 Abdulbaqi IM, Darwis Y, Khan NAK. et al. Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties,in vivo studies, and clinical trials. Int J of nanomedicine 2016; 112279
• 76 Tiwari A, Mishra MK, Shukla A. Ethosomes: a Novel Vesicular Carrier System for Therapeutic Application. IOSR journal of Pharmacy 2016; 25-33
• 77 Jaafar-Maalej C, Diab R, Andrieu V. et al. Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation. Journal of liposome research 2010; 20: 228-243
• 78 Godin B, Touitou E. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J of controlled Release 2004; 94: 365-379
• 79 Chaurasiya P, Ganju E, Upmanyu N. et al. Transfersomes: a novel technique for transdermal drug delivery. J of Drug Delivery and Therapeutics 2019; 9: 279-285
• 80 Singh D, Pradhan M, Nag M. et al. Vesicular system: Versatile carrier for transdermal delivery of bioactives. Artificial cells, nanomedicine, and biotechnology 2015; 43: 282-290
• 81 Sravani A, Shyamala SJ. An Updated Review on Transethosomes. World J Pharm Res 2019; 8: 629-637
• 82 Gondkar SB, Patil NR, Saudagar RB. Formulation development and characterization of etodolac loaded transethosomes for transdermal delivery. Research J of pharmacy and tech 2017; 10: 3049-3057
• 83 Walve JR, Bakliwal SR, Rane BR. et al. Transfersomes: a surrogated carrier for transdermal drug delivery system. Int J Appl Biol Pharm Technol 2011; 2: 204-213
• 84 Zhou Y, Wei Y, Liu H. et al. Preparation and in vitro evaluationof ethosomal total alkaloids of Sophora alopecuroides loaded by a transmembrane pH- gradient method. Aaps Pharmscitech 2010; 11: 1350-1358
• 85 Chen ZX, Li B, Liu T. et al. Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers. Eur J of pharmaceutical sci 2017; 99240-99245
• 86 Garg V, Singh H, Bhatia A. et al. Systematic development of transethosomal gel system of piroxicam: formulation optimization, in vitro evaluation, and ex vivo assessment. AAPS pharmscitech 2017; 18: 58-71
• 87 Kim JE, Oh GH, Jang GH. et al. Transformer-ethosomes with palmitoyl pentapeptide for improved transdermal delivery. J of Drug Delivery Sci and Technology 2019; 52460-52467
• 88 Dragicevic-Curic N, Grafe S, Gitter B. et al. Surface charged temoporfin-loaded flexible vesicles: in vitro skin penetration studies and stability. Int J of pharmaceutics 2010; 384: 100-108
• 89 Nimmy JK, Krishnakumar DB, Nair SK. Ethosomal gel: a review. Eur J Pharm Med Res 2017; 4: 301-305
• 90 Azizah N, Sagita E. In vitro penetration tests of transethosome gel preparations containing capsaicin. IntJ of Applied Pharmaceutics. 2017; 9116–9119
• 91 Pandey S, Misra SK, Sharma N. Ethosomes-a novelize vesicular drug delivery system. Research Jof Pharmacy and Technology 2017; 10: 3223-3232
• 92 Wagner A, Vorauer-Uhl K. Liposome technology for industrial purposes. Journal of drug delivery 2011; 20119
• 93 Guo J, Ping Q, Sun G. et al. Lecithin vesicular carriers for transdermal delivery of cyclosporin A. Int J of Pharmaceutics 2000; 194: 201-207
• 94 Akhtar N, Varma A, Pathak K. Ethosomes as vesicles for effective transdermal delivery: from bench to clinical implementation. Current clinical pharmacology 2016; 11: 168-190
• 95 Kaur P, Garg V, Bawa P. et al. Formulation, systematic optimization, in vitro, ex vivo and stability assessment of transethosome based gel of curcumin. Asian J Pharm Clin Res 2018; 11: 41-47
• 96 Jain S, Tiwary AK, Sapra B. et al. Formulation and evaluation of ethosomesfor transdermal delivery of lamivudine. Aaps Pharmscitech 2007; 8: 249-257
• 97 Maghraby GM, Williams AC, Barry BW. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J of pharmaceutics 2000; 196: 63-74
• 98 Fry DW, White JC, Goldman ID. Rapid separation of low molecular weight solutes from liposomes without dilution. Analytical biochemistry 1978; 90: 809-815
• 99 Donatella P, Giuseppe L, Domenico M. et al. Ethosomes forskin delivery of ammonium glycyrrhizinate permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Cont Release 2005; 10699-110
• 100 Dubey V, Mishra D, Nahar M. et al. Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes. Nanomedicine, Nano, Biology and Medicine 2010; 6: 590-596
• 101 Song CK, Balakrishnan P, Shim CK. et al. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids and surfaces B: biointerfaces 2012; 92299-92304
• 102 Kirjavainen M, Urtti A, Valjakka-Koskela R. et al. Liposome – skin interactions and their effects on the skin permeation of drugs. Eur J of pharmaceutical Sci 1999; 7: 279-286
• 103 Lopez-Pinto JM, Gonzalez-Rodriguez ML, Rabasco AM. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J of pharmaceutics 2005; 298: 1-12
• 104 Salem HF, Nafady MM, Kharshoum RM. et al. Mitigation of rheumatic arthritis in a rat model via transdermal delivery of dapoxetine HCl amalgamated as a nanoplatform: in vitro and in vivo assessment. Int J of nanomedicine 2020; 15: 1517-1525
• 105 Van den Bergh BAI, Swartzendruber DC, Bos-Van der Geest A. et al. Development of an optimal protocol for the ultrastructural examination of skin by transmission electron microscopy. J of microscopy 1997; 187: 125-133
• 106 Gadad AP, Patil AS, Singh Y. et al. Development and Evaluation of Flurbiprofen Loaded Transethosomes to Improve Transdermal Delivery. Indian J of Pharmaceutical Educationand Research 2020; 54: 954-962
• 107 Song H, Wen J, Li H. et al. Enhanced transdermal permeability and drug deposition of rheumatoid arthritis via sinomenine hydrochloride-loaded antioxidant surface transethosome. Int J of Nanomedicine 2019; 14: 3177-3188
• 108 Wang Y, Wang R, Qi X. et al. Novel transethosomes for the delivery of brucine and strychnine: Formulation optimization, characterization and in vitro evaluation in hepatoma cells. J of Drug Delivery Science and Technology 2021; 64: 102425
• 109 Azizah N, Sagita E. In vitro penetration tests of transethosome gel preparations containing capsaicin. Int J of Applied Pharmaceutics 2017; 9116–9119
• 110 Salem HF, Nafady MM, Kharshoum RM. et al. Mitigation of rheumatic arthritis in a rat model via transdermal delivery of dapoxetine HCl amalgamated as a nanoplatform: in vitro and in vivo assessment. Int J of nanomedicine 2020; 15: 1517-1525
• 111 El-Zaafarany GM, Abdel-Aziz RT, Montaser MA. et al. Coenzyme Q10 phospholipidic vesicular formulations for treatment of androgenic alopecia: ex vivo permeation and clinical appraisal. Expert opinion on drug delivery 2021; 18: 1513-1522
• 112 Rady M, Gomaa I, Afifi N. et al. Dermal delivery of Fe-chlorophyllin via ultradeformable nanovesicles for photodynamic therapy in melanoma animal model. Int J of Pharmaceutics 2018; 548: 480-490
• 113 Ramadon D, Pramesti SS, Anwar E. Formulation, stability test and in vitro penetration study of transethosomal gel containing green tea (Camellia sinensis L. Kuntze) leaves extract. Int J Appl Pharm 2017; 9: 91-96
• 114 Ma M, Wang J, Guo F. et al. Development of nanovesicular systems for dermal imiquimod delivery: physicochemical characterization and in vitro/in vivo evaluation. J of materials science: materials in medicine 2015; 26: 1-11
• 115 Ahmed TA, Alzahrani MM, Sirwi A. et al. The antifungal and ocular permeation of ketoconazole from ophthalmic formulations containing trans- ethosomes nanoparticles. Pharmaceutics 2021; 13: 151
• 116 Gupta V, Joshi NK. Formulation, Development and Evaluation of Ketoprofen Loaded Transethosomes Gel. J of Drug Delivery and Therapeutics 2022; 12: 86-90
• 117 Basto R, Andrade R, Nunes C. et al. Topical Delivery of Niacinamide to Skin Using Hybrid Nanogels Enhances Photoprotection Effect. Pharmaceutics 2021; 13: 1968
• 118 Albash R, Abdelbary AA, Refai H. et al. Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation. Int J of nanomedicine 2019; 141953
• 119 Chen ZX, Li B, Liu T. et al. Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers. Eur J of pharmaceutical Sci 2017; 99240-99245
• 120 Salem HF, Kharshoum RM, Abou-Taleb HA. et al. Progesterone-loaded nanosized transethosomes for vaginal permeation enhancement: formulation, statistical optimization, and clinical evaluation in anovulatory polycystic ovary syndrome. J of Liposome Research 2019; 9: 183-194
• 121 Arora D, Khurana B, Nanda S. Statistical development and in vivo evaluation of resveratrol-loaded topical gel containing deformable vesicles for a significant reduction in photo-induced skin aging and oxidative stress. Drug Development and Industrial Pharmacy 2020; 46: 1898-1910
• 122 Song H, Wen J, Li H. et al. Enhanced transdermal permeability and drug deposition of rheumatoid arthritis via sinomenine hydrochloride-loaded antioxidant surface transethosome. Int J of Nanomedicine 2019; 143177
• 123 Teaima M, Abdelmonem R, Adel YA. et al. Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats. Drug design, development and therapy 2021; 154603
• 124 Nasr M, Wahdan SA. Neuroprotective effects of novel nanosystems simultaneously loaded with vinpocetine and piracetam after intranasal administration. Life sciences 2019; 226117-226129
• 125 Song CK, Balakrishnan P, Shim CK. et al. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids and surfaces B: biointerfaces 2012; 92299-92304